Found: 15
Select item for more details and to access through your institution.
Vildagliptin plus metformin combination therapy provides superior glycaemic control to individual monotherapy in treatment-naive patients with type 2 diabetes mellitus.
- Published in:
- Diabetes, Obesity & Metabolism, 2009, v. 11, n. 5, p. 506, doi. 10.1111/j.1463-1326.2009.01040.x
- By:
- Publication type:
- Article
Reproducibility of hepatic triglyceride content assessment in normals using localized magnetic resonance spectroscopy.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Insulin therapy in type 2 diabetes: what is the evidence?
- Published in:
- Diabetes, Obesity & Metabolism, 2009, v. 11, n. 5, p. 415, doi. 10.1111/j.1463-1326.2008.00981.x
- By:
- Publication type:
- Article
PROMAXX<sup>®</sup> inhaled insulin: safe and efficacious administration with a commercially available dry powder inhaler.
- Published in:
- Diabetes, Obesity & Metabolism, 2009, v. 11, n. 5, p. 455, doi. 10.1111/j.1463-1326.2008.00961.x
- By:
- Publication type:
- Article
Lipohypertrophy: does it matter in daily life? A study using a continuous glucose monitoring system.
- Published in:
- Diabetes, Obesity & Metabolism, 2009, v. 11, n. 5, p. 460, doi. 10.1111/j.1463-1326.2008.00972.x
- By:
- Publication type:
- Article
Successful switch from insulin therapy to treatment with pioglitazone in type 2 diabetes patients with residual β-cell function: results from the PioSwitch Study.
- Published in:
- Diabetes, Obesity & Metabolism, 2009, v. 11, n. 5, p. 464, doi. 10.1111/j.1463-1326.2008.00975.x
- By:
- Publication type:
- Article
News and Views.
- Published in:
- Diabetes, Obesity & Metabolism, 2009, v. 11, n. 5, p. 523, doi. 10.1111/j.1463-1326.2009.01065.x
- By:
- Publication type:
- Article
The role of metabolic derangements and glucocorticoid excess in the aetiology of cognitive impairment in type 2 diabetes. Implications for future therapeutic strategies.
- Published in:
- Diabetes, Obesity & Metabolism, 2009, v. 11, n. 5, p. 407, doi. 10.1111/j.1463-1326.2008.00963.x
- By:
- Publication type:
- Article
Treatment of diabetic hypertension.
- Published in:
- Diabetes, Obesity & Metabolism, 2009, v. 11, n. 5, p. 433, doi. 10.1111/j.1463-1326.2008.00983.x
- By:
- Publication type:
- Article
Biomarkers of body iron stores and risk of developing type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2009, v. 11, n. 5, p. 472, doi. 10.1111/j.1463-1326.2008.00985.x
- By:
- Publication type:
- Article
Update on therapeutic strategies to increase adiponectin function and secretion in metabolic syndrome.
- Published in:
- Diabetes, Obesity & Metabolism, 2009, v. 11, n. 5, p. 445, doi. 10.1111/j.1463-1326.2008.00986.x
- By:
- Publication type:
- Article
Antioxidants attenuate hyperglycaemia-mediated brain endothelial cell dysfunction and blood–brain barrier hyperpermeability.
- Published in:
- Diabetes, Obesity & Metabolism, 2009, v. 11, n. 5, p. 480, doi. 10.1111/j.1463-1326.2008.00987.x
- By:
- Publication type:
- Article
Rosiglitazone protects diabetic rats against kidney injury through the suppression of renal matrix metalloproteinase-9 expression.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Treatment choice and effectiveness of adding sulphonylurea or glitazones to metformin for the treatment of type 2 diabetes mellitus.
- Published in:
- Diabetes, Obesity & Metabolism, 2009, v. 11, n. 5, p. 491, doi. 10.1111/j.1463-1326.2008.00991.x
- By:
- Publication type:
- Article
Safety, tolerability, pharmacodynamics and pharmacokinetics of albiglutide, a long-acting glucagon-like peptide-1 mimetic, in healthy subjects.
- Published in:
- Diabetes, Obesity & Metabolism, 2009, v. 11, n. 5, p. 498, doi. 10.1111/j.1463-1326.2008.00992.x
- By:
- Publication type:
- Article